Cat. No. |
Product Name |
Information |
PC-38147 |
eCIRP/TREM-1 inhibitor M3
eCIRP/TREM-1 inhibitor
|
eCIRP/TREM-1 inhibitor M3 (RGFFRGG) is a small CIRP-derived peptide that inhibits the eCIRP/TREM-1 interaction. |
PC-38144 |
InhiTinib
IFN-gamma inhibitor
|
InhiTinib is a small molecule that inhibit interferon (IFN)-gamma production (IC50=52.44 nM) and proliferation of primary CD3+ T cells without inducing cell death. |
PC-38132 |
UAB126
|
UAB126 (UAB 126) is a novel rexinoid-like small molecule that show positive effects on metabolic syndrome without the known side effects of potent rexinoids. |
PC-38123 |
SOX11 inhibitor Compound E
SOX11 inhibitor
|
SOX11 inhibitor Compound E (SOX11i) is a small molecule inhibitor of SOX11, bind directly to SOX11-DBD and interfere with DNA binding. |
PC-38122 |
SOX11 inhibitor Compound R
SOX11 inhibitor
|
SOX11 inhibitor Compound R (SOX11i) is a small molecule inhibitor of SOX11, bind directly to SOX11-DBD and interfere with DNA binding. |
PC-38115 |
SLC6A19 inhibitor 39
SLC6A19 inhibitor
|
SLC6A19 inhibitor 39 is a potent, selective and orally efficacious inhibitor of neutral amino acid transporter B0AT1 (SLC6A19) with IC50 of 35 nM. |
PC-38114 |
T-690
Glucosylceramide synthase inhibitor
|
T-690 is a potent, selective, oral inhibitor of glucosylceramide synthase (GCS) with IC50 of 15 nM. |
PC-38105 |
RA5557
UGT8 inhibitor
|
RA 5557 is a brain-penetrant, selective, oral UGT8 inhibitor, inhibits galactosylceramide biosynthesis. |
PC-38098 |
PXS-5129A
LOXL2 inhibitor
|
PXS-5129A is the pro-drug form of PXS-5120A, a potent, selective, irreversible inhibitor of Lysyl oxidase-like 2 (LOXL2). |
PC-38097 |
PXS-5120A
LOXL2 inhibitor
|
PXS-5120A is a potent, selective, irreversible inhibitor of Lysyl oxidase-like 2 (LOXL2) with IC50 of 5 and 6 nM (hLOXL2 and mLOXL2). |
PC-38093 |
MSDC-0602
MPC inhibitor
|
MSDC-0602 (Azemiglitazone) is a PPARγ-sparing thiazolidinedione insulin sensitizer, targets mitochondrial pyruvate carrier protein (MPC) Mpc1 and Mpc2. |
PC-38092 |
MSDC-0602K
|
MSDC-0602K (Azemiglitazone) is a PPARγ-sparing thiazolidinedione insulin sensitizer, targets mitochondrial pyruvate carrier protein (MPC) Mpc1 and Mpc2. |